For the quarter ending 2025-09-30, COCH made $42,000 in revenue. -$7,747,000 in net income. Net profit margin of -18445.24%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net revenues | 42,000 | 78,000 | 46,000 | 50,500 |
| Cost of goods sold | 203,000 | 234,000 | 226,000 | 155,000 |
| Research and development | 2,700,000 | 2,485,000 | 2,748,000 | 2,415,500 |
| Sales and marketing | 405,000 | 361,000 | 358,000 | 421,500 |
| General and administrative | 2,442,000 | 2,068,000 | 1,821,000 | 1,769,500 |
| Total costs and operating expenses | 5,750,000 | 5,148,000 | 5,153,000 | 4,761,500 |
| Change in fair value of forward purchase agreement put option liability | - | 0 | - | 25,750 |
| Operating loss | -5,708,000 | -5,070,000 | -5,107,000 | -4,711,000 |
| Change in fair value of forward purchase agreement warrant liability | -64,000 | -37,000 | -421,000 | -239,000 |
| Change in fair value of private warrant liability | 339,000 | - | - | - |
| Change in fair value of publicly traded warrant liability | 33,000 | 32,000 | -194,000 | 352,500 |
| Interest expense, related party | 471,000 | 624,000 | 495,000 | 204,000 |
| Change in fair value of forward purchase agreement warrant liability due to modification | - | - | - | 12,916.667 |
| Other income (expense), net | 5,000 | -1,000 | -11,000 | -13,666.667 |
| Total other income (expense), net | -774,000 | -620,000 | 109,000 | -733,000 |
| Net loss | -6,482,000 | -5,690,000 | -4,998,000 | -5,444,000 |
| Cumulative preferred dividends | 1,265,000 | 1,252,000 | 1,238,000 | 1,380,250 |
| Induced conversion of series a preferred stock into class a common stock | - | - | - | 290,500 |
| Deemed dividend on waiver of restriction on class a common stock | - | - | - | 484,583.333 |
| Net loss attributable to common stockholders, basic | -7,747,000 | -6,942,000 | -6,236,000 | -6,877,666.667 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.35 | -0.32 | -0.29 | -0.425 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.35 | -0.32 | -0.29 | -0.425 |
| Weighted-average class a common stock outstanding, basic (in shares) | 21,851,606 | 21,383,852 | 21,326,609 | -10,212,948 |
| Weighted-average class a common stock outstanding, diluted (in shares) | 21,851,606 | 21,383,852 | 21,326,609 | -10,212,948 |
Envoy Medical, Inc. (COCH)
Envoy Medical, Inc. (COCH)